NCT01071044: Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome |
|
|
| Completed | 4 | 26 | US | Lisdexamfetamine Dimesylate, Vyvanse, Placebo "30, 50 or 70 mg", Sugar pill | Rochester Center for Behavioral Medicine, Shire | Chronic Fatigue Syndrome, Cognitive Impairments | 03/11 | 03/11 | | |
NCT01324024: Attention & Memory Impairments in Menopausal Women |
|
|
| Completed | 4 | 35 | US | Lisdexamfetamine, Vyvanse®, Placebo | University of Pennsylvania, Shire | Symptomatic Menopause, Cognitive Impairments | 04/14 | 04/14 | | |
NCT01148979: Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder. |
|
|
| Completed | 4 | 35 | US | Lisdexamfetamine Dimesylate (Vyvanse), Vyvanse, Placebo, Sugar pill | Mclean Hospital, Shire | Major Depressive Disorder | 09/14 | 10/14 | | |
